- Slice of Manufacturing
- Posts
- Arclin Expands North American Methylamines and DMF Production with Major Investment
Arclin Expands North American Methylamines and DMF Production with Major Investment
Slice of Manufacturing Team
August 27, 2024
Key Highlights:
Arclin increases methylamine capacity by 35% and DMF by 100% at its West Virginia facility.
Investment responds to growing domestic demand across industries like pharmaceuticals, nutrition, and electronics.
Potential addition of formamide production capabilities under consideration.
Source (PR Newswire)
Notable Quotes:
"This investment speaks to Arclin's excitement and commitment to the methylamines and derivatives business. The additional capacity will allow us to meet growing demand across a variety of critical industries including pharmaceuticals, nutrition, water treatment, and electronics and further promote our company goal to diversify our product offerings to the market."
"We are proud to play a pivotal role in expanding the production of methylamine and methylamide products for our customers. This expansion not only reflects our dedication to meeting the growing needs of our customers but also showcases the exceptional work and commitment of our Belle facility workforce."
Our Take:
Arclin's decision to expand its production capacity significantly highlights the increasing importance of domestic production in the chemicals sector, especially as global supply chains face disruptions. By doubling its DMF capacity and substantially increasing methylamine output, Arclin is not only positioning itself to meet the rising demand but also reinforcing its commitment to innovation and diversification within the industry. This strategic move is likely to enhance Arclin's competitive edge in the North American market, particularly in sectors that are critical to the economy, such as pharmaceuticals and electronics.